Oricell Therapeutics
Latest round
- Series C
Last raised
- Jan 2026
Total raised
- $277M
Investors
- 17
About Oricell Therapeutics
, trading as Oricell Therapeutics, is a biotech company that focuses on the research and development of tumor immune cell therapy products. The company was formerly the research and development center of The Origincell Technology Group. The company has established subsidiaries in Hong Kong and the United States. The company's main product pipeline includes autologous CAR-T immunotherapy products for the treatment of advanced hepatocellular carcinoma, relapsed refractory multiple myeloma and other novel drugs for tumor immunotherapy. The company's products are used in diseases such as liver cancer, ovarian cancer, gastric cancer and cervical cancer. The company generates revenue from developing cell therapies leveraging CAR-T technology.
Who invested in Oricell Therapeutics
17 investors across 5 rounds
See all investors in Oricell Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oricell Therapeutics
Who invested in Oricell Therapeutics?
Oricell Therapeutics has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oricell Therapeutics raised?
Oricell Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Oricell Therapeutics last raise money?
Oricell Therapeutics's most recent round on record is a Series C, in Jan 2026.
What does Oricell Therapeutics do?
, trading as Oricell Therapeutics, is a biotech company that focuses on the research and development of tumor immune cell therapy products.
Where is Oricell Therapeutics headquartered?
Oricell Therapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like Oricell Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Oricell Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Oricell Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.